Framatome signed two contracts with NRG to supply enriched uranium targets and fuel elements for the High Flux Reactor (HFR) in the Netherlands. The HFR research reactor produces more than 60% of Europe's medical isotopes, primarily for the use in diagnostic nuclear imaging scans.

"We are pleased to continue our long partnership with NRG and to contribute to the accessibility of critical medical radioisotopes worldwide," said Francois Gauche, director of Framatome Healthcare and vice president of CERCA of the Fuel Business Unit at Framatome.

"With more than 40 million nuclear medicine procedures performed worldwide each year, we are proud to be a key supplier of fuel for research reactors to help meet this critical demand."

These new contracts call for a multi-year supply of fuel elements for the HFR and of uranium targets to produce the radioisotope Mo-99 among others. The fuel will come from the Framatome CERCA fuel manufacturing facility in Romans, France. For more than 60 years CERCA has been producing nuclear fuel and uranium targets for research reactors.

NRG has been a Framatome customer for more than two decades and this strong partnership was key in finalizing these agreements. Framatome is committed to support NRG in the continuous safe and efficient operation of the HFR reactor for the benefits of the scientific and nuclear medicine communities.

Related Links
Framatome
Nuclear Power News - Nuclear Science, Nuclear Technology
Powering The World in the 21st Century at Energy-Daily.com

Tweet

Thanks for being here; We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain. With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords. Our news coverage takes time and effort to publish 365 days a year. If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor $5 Billed Once credit card or paypal		SpaceDaily Monthly Supporter $5 Billed Monthly paypal only

BWXT Starts Production of TRISO Fuel for First U.S. Generation IV Microreactor
Lynchburg VA (SPX) Dec 08, 2022
BWX Technologies, Inc. (NYSE: BWXT) with officials from the U.S. Department of Defense, Department of Energy, NASA and Idaho National Laboratory celebrated the landmark production of TRISO nuclear fuel that will power the first microreactor built and operated in the United States. The Department of Energy (DOE) calls TRISO "the most robust nuclear fuel on earth." The small, energy-dense coated uranium particles can withstand high temperatures, enabling smaller and more advanced reactor designs. ... read more